Food allergy: Recent advances in pathophysiology and treatment

Annual Review of Medicine

Volumn 60, Issue , 2009, Pages 261-277

  Sicherer, Scott H ^a   Sampson, Hugh A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Anaphylaxis; Food allergens; Food hypersensitivity; Immunotherapy; Oral tolerance

Indexed keywords

ADRENALIN; ARA H 2 ALLERGEN; HERBACEOUS AGENT; INTERLEUKIN 10; INTERLEUKIN 4; LYMPHOTOXIN; OMALIZUMAB; PLASMID DNA; RECOMBINANT ALLERGEN; STEROID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ASTHMA; ATOPIC DERMATITIS; CELL HOMING; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; CHILD; CHINESE MEDICINE; CLINICAL TRIAL; DRUG MECHANISM; ENTEROCOLITIS; EOSINOPHILIC GASTROENTERITIS; FOOD ALLERGY; HUMAN; MULTICENTER STUDY; NONHUMAN; NUTRITIONAL INTOLERANCE; PATIENT EDUCATION; PRIORITY JOURNAL; PROCTITIS; PROTEIN INTAKE; REVIEW; RHINITIS; URTICARIA;

FOOD HYPERSENSITIVITY; HUMANS;

EID: 67650762842     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.med.60.042407.205711     Document Type: Review

References (92)

1. Sicherer SH, Sampson HA. 2006. 9. Food allergy. J. Allergy Clin. Immunol. 117:S470-75
2. Rona RJ, Keil T, Summers C, et al. 2007. The prevalence of food allergy: a meta-analysis. J. Allergy Clin. Immunol. 120:638-46
3. Sicherer SH, Munoz-Furlong A, Sampson HA. 2003. Prevalence of peanut and tree nut allergy in the United States determined by means of a random digit dial telephone survey: a 5-year follow-up study. J. Allergy Clin. Immunol. 112:1203-7
4. Grundy J, Matthews S, Bateman B, et al. 2002. Rising prevalence of allergy to peanut in children: data from 2 sequential cohorts. J. Allergy Clin. Immunol. 110:784-89
5. Hourihane JO, Aiken R, Briggs R, et al. 2007. The impact of government advice to pregnant mothers regarding peanut avoidance on the prevalence of peanut allergy in United Kingdom children at school entry. J. Allergy Clin. Immunol. 119:1197-202
6. Chapman JA, Bernstein IL, Lee RE, et al. 2006. Food allergy: a practice parameter. Ann. Allergy Asthma Immunol. 96:S1-68
7. Sampson HA. 2001. Utility of food-specific IgE concentrations in predicting symptomatic food allergy. J. Allergy Clin. Immunol. 107:891-96
8. Astier C, Morisset M, Roitel O, et al. 2006. Predictive value of skin prick tests using recombinant allergens for diagnosis of peanut allergy. J. Allergy Clin. Immunol. 118:250-56
9. Flinterman AE, Knol EF, Lencer DA, et al. 2008. Peanut epitopes for IgE and IgG4 in peanut-sensitized children in relation to severity of peanut allergy. J. Allergy Clin. Immunol. 121:737-43
10. Shreffler WG, Beyer K, Chu TH, et al. 2004. Microarray immunoassay: association of clinical history, in vitro IgE function, and heterogeneity of allergenic peanut epitopes. J. Allergy Clin. Immunol. 113:776-82
11. Vadas P, Gold M, Perelman B, et al. 2008. Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis. N. Engl. J. Med. 358:28-35
12. Bock SA, Munoz-Furlong A, Sampson HA. 2007. Further fatalities caused by anaphylactic reactions to food, 2001-2006. J. Allergy Clin. Immunol. 119:1016-18
13. Steckelbroeck S, Ballmer-Weber BK,Vieths S. 2008. Potential, pitfalls, and prospects of food allergy diagnostics using recombinant allergens or synthetic sequential epitopes. J. Allergy Clin. Immunol. 121:1323-30
14. Sicherer SH, Furlong TJ, Maes HH, et al. 2000. Genetics of peanut allergy: a twin study. J. Allergy Clin. Immunol. 106:53-56
15. Lack G. 2008. Epidemiological risk factors for food allergy. J. Allergy Clin. Immunol. 121:1331-36
16. Fernandez-Rivas M, Bolhaar S, Gonzalez-Mancebo E, et al. 2006. Apple allergy across Europe: how allergen sensitization profiles determine the clinical expression of allergies to plant foods. J. Allergy Clin. Immunol. 118:481-88
17. Navuluri L, Parvataneni S, Hassan H, et al. 2006. Allergic and anaphylactic response to sesame seeds in mice: identification of Ses i 3 and basic subunit of 11s globulins as allergens. Int. Arch. Allergy Immunol. 140:270-76
18. Strid J, Thomson M, Hourihane J, et al. 2004. A novel model of sensitization and oral tolerance to peanut protein. Immunology 113:293-303
19. Lack G, Fox D, Northstone K, et al. 2003. Factors associated with the development of peanut allergy in childhood. N. Engl. J. Med. 348:977-85
20. Hill DJ, Hosking CS, de Benedictis FM, et al. 2008. Confirmation of the association between high levels of immunoglobulin E food sensitization and eczema in infancy: an international study. Clin. Exp. Allergy 38:161-68
21. Chehade M, Mayer L. 2005. Oral tolerance and its relation to food hypersensitivities. J. Allergy Clin. Immunol. 115:3-12
22. Untersmayr E, Jensen-Jarolim E. 2008. The role of protein digestibility and antacids on food allergy outcomes. J. Allergy Clin. Immunol. 121:1301-8
23. Mowat AM. 2003. Anatomical basis of tolerance and immunity to intestinal antigens. Nat. Rev. Immunol. 3:331-41
24. Strobel S, Mowat AM. 2006. Oral tolerance and allergic responses to food proteins. Curr. Opin. Allergy Clin. Immunol. 6:207-13
25. Frossard CP, Tropia L, Hauser C, et al. 2004. Lymphocytes in Peyer patches regulate clinical tolerance in a murine model of food allergy. J. Allergy Clin. Immunol. 113:958-64
26. St Clair EW, Turka LA, Saxon A, et al. 2007. New reagents on the horizon for immune tolerance. Annu. Rev. Med. 58:329-46
27. Sudo N, Sawamura S, Tanaka K, et al. 1997. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J. Immunol. 159:1739-45
28. Bashir ME, Louie S, Shi HN, et al. 2004. Toll-like receptor 4 signaling by intestinal microbes influences susceptibility to food allergy. J. Immunol. 172:6978-87
29. Prescott SL, Bjorksten B. 2007. Probiotics for the prevention or treatment of allergic diseases. J. Allergy Clin. Immunol. 120:255-62
30. Torgerson TR, Ochs HD. 2007. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked: forkhead box protein 3 mutations and lack of regulatory T cells. J. Allergy Clin. Immunol. 120:744-50
31. + regulatory T cells in children who have outgrown cow's milk allergy. J. Exp. Med. 199:1679-88
32. + T cells regulate the intensity of hypersensitivity responses to peanut, but are not decisive in the induction of oral sensitization. Clin. Exp. Allergy 37:572-81
33. Blazquez AB, Berin MC. 2008. Gastrointestinal dendritic cells promote Th2 skewing via OX40L. J. Immunol. 180:4441-50
34. Yang PC, Xing Z, Berin CM, et al. 2007. TIM-4 expressed by mucosal dendritic cells plays a critical role in food antigen-specific Th2 differentiation and intestinal allergy. Gastroenterologica 133:1522-33
35. Turcanu V, Maleki SJ, Lack G. 2003. Characterization of lymphocyte responses to peanuts in normal children, peanut-allergic children, and allergic children who acquired tolerance to peanuts. J. Clin. Invest. 111:1065-72
36. Thottingal TB, Stefura BP, Simons FE, et al. 2006. Human subjects without peanut allergy demonstrate T cell-dependent, TH2-biased, peanut-specific cytokine and chemokine responses independent of TH1 expression. J. Allergy Clin. Immunol. 118:905-14
37. Abernathy-Carver K, Sampson H, Picker L, et al. 1995. Milk-induced eczema is associated with the expansion of T cells expressing cutaneous lymphocyte antigen. J. Clin. Invest. 95:913-18
38. Reekers R, Busche M, Wittmann M, et al. 1999. Birch pollen-related foods trigger atopic dermatitis in patients with specific cutaneous T-cell responses to birch pollen antigens. J. Allergy Clin. Immunol. 104:466-72
39. Bohle B, Zwolfer B, Heratizadeh A, et al. 2006. Cooking birch pollen-related food: divergent consequences for IgE- and T cell-mediated reactivity in vitro and in vivo. J. Allergy Clin. Immunol. 118:242-49
40. Sampson HA. 1999. Food allergy. Part 1: Immunopathogenesis and clinical disorders. J. Allergy Clin. Immunol. 103:717-28
41. Knight AK, Blazquez AB, Zhang S, et al. 2007. CD4 T cells activated in the mesenteric lymph node mediate gastrointestinal food allergy in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 293:G1234-43
42. Eigenmann PA, Tropia L, Hauser C. 1999. The mucosal adhesion receptor alpha4beta7 integrin is selectively increased in lymphocytes stimulated with beta-lactoglobulin in children allergic to cow's milk. J. Allergy Clin. Immunol. 103:931-36
43. Benlounes N, Candalh C, Matarazzo P, et al. 1999. The time-course of milk antigen-induced TNF-alpha secretion differs according to the clinical symptoms in children with cow's milk allergy. J. Allergy Clin. Immunol. 104:863-69
44. Chung HL,Hwang JB, Park JJ, et al. 2002. Expression of transforming growth factor beta1, transforming growth factor type I and II receptors, and TNF-alpha in the mucosa of the small intestine in infants with food protein-induced enterocolitis syndrome. J. Allergy Clin. Immunol. 109:150-54
45. Furuta GT, Liacouras CA, Collins MH, et al. 2007. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterologica 133:1342-63
46. Liacouras CA, Spergel JM, Ruchelli E, et al. 2005. Eosinophilic esophagitis: a 10-year experience in 381 children. Clin. Gastroenterol. Hepatol. 3:1198-206
47. Blanchard C, Wang N, Stringer KF, et al. 2006. Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J. Clin. Invest. 116:536-47
48. Blanchard C, Mingler MK, Vicario M, et al. 2007. IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucocorticoids. J. Allergy Clin. Immunol. 120:1292-300
49. Radauer C, Breiteneder H. 2007. Evolutionary biology of plant food allergens. J. Allergy Clin. Immunol. 120:518-25
50. Jenkins JA, Breiteneder H, Mills EN. 2007. Evolutionary distance from human homologs reflects allergenicity of animal food proteins. J. Allergy Clin. Immunol. 120:1399-405
51. Sicherer SH, Sampson HA. 2007. Peanut allergy: emerging concepts and approaches for an apparent epidemic. J. Allergy Clin. Immunol. 120:491-503
52. Maleki SJ, Viquez O, Jacks T, et al. 2003. The major peanut allergen, Ara h 2, functions as a trypsin inhibitor, and roasting enhances this function. J. Allergy Clin. Immunol. 112:190-95
53. Beyer K, Morrow E, Li XM, et al. 2001. Effects of cooking methods on peanut allergenicity. J. Allergy Clin. Immunol. 107:1077-81
54. Shreffler WG, Castro RR, Kucuk ZY, et al. 2006. The major glycoprotein allergen from Arachis hypogaea, Ara h 1, is a ligand of dendritic cell-specific ICAM-grabbing nonintegrin and acts as a Th2 adjuvant in vitro. J. Immunol. 177:3677-85
55. Meyer S, van Liempt E, Imberty A, et al. 2005. DC-SIGN mediates binding of dendritic cells to authentic pseudo-LewisY glycolipids of Schistosoma mansoni cercariae, the first parasite-specific ligand of DC-SIGN. J. Biol. Chem. 280:37349-59
56. Stanley JS, King N, Burks AW, et al. 1997. Identification and mutational analysis of the immunodominant IgE binding epitopes of the major peanut allergen Ara h 2. Arch. Biochem. Biophys. 342:244-53
57. JointTask Force on Practice Parameters: American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology. 2007. Allergen immunotherapy: a practice parameter second update. J. Allergy Clin. Immunol. 120:S25-85
58. Bolhaar ST, Tiemessen MM, Zuidmeer L, et al. 2004. Efficacy of birch-pollen immunotherapy on cross-reactive food allergy confirmed by skin tests and double-blind food challenges. Clin. Exp. Allergy 34:761-69
59. Nelson HS, Lahr J, Rule R, et al. 1997. Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract. J. Allergy Clin. Immunol. 99:744-51
60. Bohle B, Kinaciyan T, Gerstmayr M, et al. 2007. Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation. J. Allergy Clin. Immunol. 120:707-13
61. Enrique E, Pineda F, Malek T, et al. 2005. Sublingual immunotherapy for hazelnut food allergy: a randomized, double-blind, placebo-controlled study with a standardized hazelnut extract. J. Allergy Clin. Immunol. 116:1073-79
62. De Boissieu D, Dupont C. 2006. Sublingual immunotherapy for cow's milk protein allergy: a preliminary report. Allergy 61:1238-39
63. Patriarca G, Nucera E, Roncallo C, et al. 2003. Oral desensitizing treatment in food allergy: clinical and immunological results. Aliment. Pharmacol. Ther. 17:459-65
64. Meglio P, Bartone E, Plantamura M, et al. 2004. A protocol for oral desensitization in children with IgE-mediated cow's milk allergy. Allergy 59:980-87
65. Morisset M, Moneret-Vautrin DA, Guenard L, et al. 2007. Oral desensitization in children with milk and egg allergies obtains recovery in a significant proportion of cases. A randomized study in 60 children with cow's milk allergy and 90 children with egg allergy. Eur. Ann. Allergy Clin. Immunol. 39:12-19
66. Staden U, Rolinck-Werninghaus C, Brewe F, et al. 2007. Specific oral tolerance induction in food allergy in children: efficacy and clinical patterns of reaction. Allergy 62:1261-69
67. Longo G, Barbi E, Berti I, et al. 2007. Specific oral tolerance induction in children with very severe cow's milk-induced reactions. J. Allergy Clin. Immunol. 121:343-47
68. Buchanan AD, Green TD, Jones SM, et al. 2007. Egg oral immunotherapy in nonanaphylactic children with egg allergy. J. Allergy Clin. Immunol. 119:199-205
69. Bannon GA, Cockrell G, Connaughton C, et al. 2001. Engineering, characterization and in vitro efficacy of the major peanut allergens for use in immunotherapy. Int. Arch. Allergy Immunol. 124:70-72
70. Rabjohn P, Helm EM, Stanley JS, et al. 1999. Molecular cloning and epitope analysis of the peanut allergen Ara h 3. J. Clin. Invest. 103:535-42
71. Swoboda I, Bugajska-Schretter A, Linhart B, et al. 2007. A recombinant hypoallergenic parvalbumin mutant for immunotherapy of IgE-mediated fish allergy. J. Immunol. 178:6290-96
72. Ma Y, Gadermaier G, Bohle B, et al. 2006. Mutational analysis of amino acid positions crucial for IgE-binding epitopes of the major apple (Malus domestica) allergen, Mal d 1. Int. Arch. Allergy Immunol. 139:53-62
73. Li XM, Srivastava K, Grishin A, et al. 2003. Persistent protective effect of heat-killed Escherichia coli producing "engineered," recombinant peanut proteins in a murine model of peanut allergy. J. Allergy Clin. Immunol. 112:159-67
74. Nowak-Wegrzyn A, Sampson HA. 2004. Food allergy therapy. Immunol. Allergy Clin. North Am. 24:705-25
75. Li S, Li XM, Burks AW, et al. 2001. Modulation of peanut allergy by peptide-based immunotherapy. J. Allergy Clin. Immunol. 107:S233 (Abstr.)
76. Roy K, MaoHQ, Huang SK, et al. 1999. Oral gene delivery with chitosan-DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat. Med. 5:387-91
77. Li X, Huang CK, Schofield BH, et al. 1999. Strain-dependent induction of allergic sensitization caused by peanut allergen DNA immunization in mice. J. Immunol. 162:3045-52
78. Kattan JD, Srivastava KD, Li XM, Sampson HA. 2003. Intranasal treatment with CpG oligonucleotides provides protection from anaphylaxis in a murine model of peanut allergy. J. Allergy Clin. Immunol. 111:S206 (Abstr.)
79. Nguyen MD, Cinman N, Yen J, et al. 2001. DNA-based vaccination for the treatment of food allergy. Allergy 56(Suppl. 67):127-30
80. Leung DY, Sampson HA, Yunginger JW, et al. 2003. Effect of anti-IgE therapy in patients with peanut allergy. N. Engl. J. Med. 348:986-93
81. Sampson HA, Leung DYM, Burks AW, et al. 2007. A phase II, randomized, double-blind, parallel group, placebo-controlled, oral food challenge trial of Xolair® (omalizumab) in peanut allergy (TOPS). J. Allergy Clin. Immun. 119(1):S117 (Abstr.)
82. Foroughi S, Foster B, Kim N, et al. 2007. Anti-IgE treatment of eosinophil-associated gastrointestinal disorders. J. Allergy Clin. Immunol. 120:594-601
83. Srivastava KD, Kattan JD, Zou ZM, et al. 2005. The Chinese herbal medicine formula FAHF-2 completely blocks anaphylactic reactions in a murine model of peanut allergy. J. Allergy Clin. Immunol. 115:171-78
84. Li XM. 2007. Traditional Chinese herbal remedies for asthma and food allergy. J. Allergy Clin. Immunol. 120:25-31
85. Frossard CP, Steidler L, Eigenmann PA. 2007. Oral administration of an IL-10-secreting Lactococcus lactis strain prevents food-induced IgE sensitization. J. Allergy Clin. Immunol. 119:952-59
86. Ando T, Hatsushika K,Wako M, et al. 2007. Orally administered TGF-beta is biologically active in the intestinal mucosa and enhances oral tolerance. J. Allergy Clin. Immunol. 120:916-23
87. Stein ML, Collins MH, Villanueva JM, et al. 2006. Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis. J. Allergy Clin. Immunol. 118:1312-19
88. Frick OL, Teuber SS, Buchanan BB, et al. 2005. Allergen immunotherapy with heat-killed Listeria monocytogenes alleviates peanut and food-induced anaphylaxis in dogs. Allergy 60:243-50
89. Li XM, Srivastava K, Huleatt JW, et al. 2003. Engineered recombinant peanut protein and heat-killed Listeria monocytogenes coadministration protects against peanut-induced anaphylaxis in a murine model. J. Immunol. 170:3289-95
90. Zhu FG, Kandimalla ER, Yu D, et al. 2007. Oral administration of a synthetic agonist ofToll-like receptor 9 potently modulates peanut-induced allergy in mice. J. Allergy Clin. Immunol. 120:631-37
91. Creticos PS, Schroeder JT, Hamilton RG, et al. 2006. Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis. N. Engl. J. Med. 355:1445-55
92. Saxon A, Kepley C, Zhang K. 2008. "Accentuate the negative, eliminate the positive": engineering allergy therapeutics to block allergic reactivity through negative signaling. J. Allergy Clin. Immunol. 121:320-25